J
301130
vs
S
Shanghai Composite
Over the past 12 months, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd has underperformed Shanghai Composite, delivering a return of +14% compared to the Shanghai Composite's +24% growth.
Stocks Performance
301130 vs Shanghai Composite
Performance Gap
301130 vs Shanghai Composite
Performance By Year
301130 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Competitors Performance
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd vs Peers
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd
Glance View
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jilin, Jilin and currently employs 279 full-time employees. The company went IPO on 2022-02-23. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of chemical active pharmaceutical ingredients (APIs) and preparations. The firm's products cover the fields of anti anemia drugs, drugs for the treatment of mental disorders and the production of APIs, such as compound ferrous sulfate folic acid tablets, risperidone orally disintegrating tablets, escitalopram oxalate tablets, daphnetin capsules, sodium ferulate and ferrous fumarate.
